SAN FRANCISCO (GenomeWeb News) – Danaher will likely use at least part of its $8 billion available for acquisitions in order to expand its life science and diagnostics portfolio, company President and CEO Larry Culp said at the 32nd Annual JP Morgan Healthcare Conference here this morning.

During the firm’s analyst day meeting last month, Culp said that the firm had at its disposal about $8 billion available to pursue merger and acquisitions and today he reiterated that figure while adding that the firm “will continue to be an active acquirer” throughout 2014 and beyond.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Technology Review reports that researchers in the US have used CRISPR to modify a number of human embryos.

Plant researchers plan to sequence some 10,000 samples that represent the major plant clades, ScienceInsider reports.

By introducing genes from butterfly peas and Canterbury bells, researchers in Japan have developed a blue chrysanthemum, according to NPR.

In Nature this week: a Danish reference genome, and more.